Edition:
United Kingdom

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

3,095JPY
20 Apr 2018
Change (% chg)

¥-15 (-0.48%)
Prev Close
¥3,110
Open
¥3,085
Day's High
¥3,105
Day's Low
¥3,065
Volume
144,800
Avg. Vol
252,923
52-wk High
¥3,290
52-wk Low
¥1,930

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 7.79 March 20 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.67 2.67 2.67

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 38,491.00 38,491.00 38,491.00 --
Year Ending Mar-18 5 166,600.00 170,000.00 162,600.00 158,486.00
Year Ending Mar-19 5 173,780.00 179,800.00 167,300.00 161,133.00
Earnings (per share)
Quarter Ending Mar-18 1 7.79 7.79 7.79 --
Year Ending Mar-18 6 101.14 113.70 95.70 79.19
Year Ending Mar-19 6 109.17 129.00 99.20 83.55

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 38,540.00 42,661.00 4,121.00 10.69
Quarter Ending Mar-17 41,958.00 43,177.00 1,219.00 2.91
Quarter Ending Dec-16 37,544.00 40,124.00 2,580.00 6.87
Quarter Ending Sep-16 41,215.00 38,419.00 2,796.00 6.78
Quarter Ending Mar-16 45,800.00 46,692.00 892.00 1.95

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 38,491.00 38,491.00 38,491.00 38,491.00 --
Year Ending Mar-18 166,600.00 166,600.00 166,500.00 166,500.00 158,486.00
Year Ending Mar-19 173,780.00 173,780.00 173,780.00 173,780.00 161,133.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Year Ending Mar-18 0 0 1 0
Year Ending Mar-19 0 0 0 0
Earnings